Dr Mike Nicholds - Newcells

Retinal platform

An in vitro, light responsive, retinal model for accurate predictions of in vivo outcomes you can have confidence in.

aProximateTM

Kidney platform

The most advanced near-physiological high throughput kidney proximal tubule cells (PTC) model to investigate drug transport modalities in vitro.

Lung epithelia model

Lung model

A model to investigate airway physiology, viral infection, drug safety and environmental impacts on lung airway epithelia.

Sinusoid iPSC-derived Liver model

Liver model

We are developing a model of liver sinusoid derived from human induced pluripotent stem cells (iPSC).

Dr Mike Nicholds

CEO and Co-founder

Mike’s career spans more than 30 years in life sciences working for a range of companies in senior management and leadership roles. Trained as a microbiologist, Mike began his career during the early years of the biotechnology industry working in the technical field before transitioning into sales, marketing, business management and executive director roles. His passion is in translating life sciences into life products including biocatalysts, biologics, vaccines and stem cells working for and advising large, medium and start-up companies including ICI, Zeneca, Avecia Biologics, Chirex and spin-out investor-backed enterprises.

Headshot of Mike Nicholds